142 related articles for article (PubMed ID: 32470565)
1. The association between plasma HMGB1 and sRAGE and clinical outcome in intracerebral hemorrhage.
Lei C; Geng J; Zhong L
J Neuroimmunol; 2020 Aug; 345():577266. PubMed ID: 32470565
[TBL] [Abstract][Full Text] [Related]
2. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H
Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
4. Elevated HMGB1 and sRAGE levels in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients.
Chu XH; Hu HY; Godje ISG; Zhu LJ; Zhu JB; Feng YL; Wang H; Zhang YB; Huang J; Sun XG
J Stroke Cerebrovasc Dis; 2023 May; 32(5):107061. PubMed ID: 36871437
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
Abe H; Okada-Tsuchioka M; Kajitani N; Omori W; Itagaki K; Shibasaki C; Boku S; Matsuhisa T; Takebayashi M
Neuropsychopharmacol Rep; 2023 Sep; 43(3):359-364. PubMed ID: 37337402
[TBL] [Abstract][Full Text] [Related]
7. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
Front Immunol; 2019; 10():460. PubMed ID: 30923525
[TBL] [Abstract][Full Text] [Related]
8. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
Atzeni IM; Al-Adwi Y; Doornbos-van der Meer B; Roozendaal C; Stel A; van Goor H; Gan CT; Dickinson M; Timens W; Smit AJ; Westra J; Mulder DJ
Front Immunol; 2023; 14():1189257. PubMed ID: 37409127
[TBL] [Abstract][Full Text] [Related]
9. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
Clin Biochem; 2011 Jun; 44(8-9):601-4. PubMed ID: 21211520
[TBL] [Abstract][Full Text] [Related]
11. Functional role of soluble receptor for advanced glycation end products in stroke.
Tang SC; Wang YC; Li YI; Lin HC; Manzanero S; Hsieh YH; Phipps S; Hu CJ; Chiou HY; Huang YS; Yang WS; Mattson MP; Arumugam TV; Jeng JS
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):585-94. PubMed ID: 23288172
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the receptor for advanced glycation end products in liver transplantation.
Navarra T; De Simone P; Del Turco S; Filipponi F; Basta G
Ann Hepatol; 2015; 14(2):190-7. PubMed ID: 25671828
[TBL] [Abstract][Full Text] [Related]
13. HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage.
Lei C; Zhang S; Cao T; Tao W; Liu M; Wu B
Neuroscience; 2015 Jun; 295():39-47. PubMed ID: 25813710
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
[TBL] [Abstract][Full Text] [Related]
15. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.
Stoetzer OJ; Fersching DM; Salat C; Steinkohl O; Gabka CJ; Hamann U; Braun M; Feller AM; Heinemann V; Siegele B; Nagel D; Holdenrieder S
Tumour Biol; 2013 Feb; 34(1):81-90. PubMed ID: 22983919
[TBL] [Abstract][Full Text] [Related]
16. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
Tang KT; Hsieh TY; Chao YH; Lin MX; Chen YH; Chen DY; Lin CC
PLoS One; 2017; 12(5):e0178404. PubMed ID: 28558055
[TBL] [Abstract][Full Text] [Related]
18. Activation of the high-mobility group box 1 protein-receptor for advanced glycation end-products signaling pathway in rats during neurogenesis after intracerebral hemorrhage.
Lei C; Wu B; Cao T; Zhang S; Liu M
Stroke; 2015 Feb; 46(2):500-6. PubMed ID: 25538203
[TBL] [Abstract][Full Text] [Related]
19. [The Value of Serum HMGB1 and sRAGE in the Diagnosis, Efficacy Monitoring and Prognosis of Newly Diagnosed Multiple Myeloma].
Wang J; Zeng AM; Liang SF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):493-500. PubMed ID: 35395985
[TBL] [Abstract][Full Text] [Related]
20. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B
Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]